GOTHENBURG, Sweden, June 4, 2026 /PRNewswire/ -- Volvo Autonomous Solutions (V.A.S.) and Boliden have completed the autonomous transport project at Boliden's Garpenberg site in...
Unified Technology from ePlus, NVIDIA and Cisco Provides a Self-Contained, Fast-Acting and Secure SolutionHERNDON, Va., June 3, 2026 /PRNewswire/ -- ePlus inc. (NASDAQ NGS:...
ISS National Lab highlights space R&D and growing low Earth orbit economy at ASCEND 2026KENNEDY SPACE CENTER, Fla., June 2, 2026 /PRNewswire/ -- The International...
Embodied AI company TARS debuts DexHand globally in Vienna and demonstrates real-world precision intelligence with AWE 3.0.VIENNA, June 2, 2026 /PRNewswire/ -- TARS, the...
OTCQB: SVBL, TSX: SVBVANCOUVER, BC, June 1, 2026 /CNW/ - Silver Bull Resources, Inc. ("Silver Bull" or the "Company") announces that its Arbitration case against...
Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an additional indication for Wegovy® (semaglutide 2.4 mg) based on a supplemental New Drug Application (sNDA) for treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), in combination with a reduced calorie diet and increased physical activity.
SAN FRANCISCO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Shares of Nutex Health Inc. (NASDAQ: NUTX) experienced a precipitous decline today, falling as much as 24% in intraday trading. The significant drop followed the company’s disclosure that it would not timely submit its financial results for the quarter ended June 30, 2025 - a development related to an ongoing investigation by law firm Hagens Berman into possible securities violations.
Continued focus on enabling managed service providers as new research reveals the potential of proactive monitoring to reduce their operational costs.
As Martello continues to...